KV Pharmaceutical Company is a fully integrated specialty pharmaceutical company that develops, manufactures, markets and acquires technologydistinguished branded and generic/non-branded prescription pharmaceutical products. The Company markets its technology-distinguished products through ETHEX Corporation, a national leader in pharmaceuticals that compete with branded products, and Ther-Rx Corporation, its branded prescription pharmaceutical subsidiary.
Acrux Limited (ASX:ACR) and KV Pharmaceutical (NYSE:KV-A) Launch EVAMIST Skin Spray Drug Delivery Technology in US
Acrux (ASX: ACR)(PNK:ARUXF) today announced that Evamist(tm), the first product utilising its unique skin spray drug delivery technology, has been launched by US licensee KV Pharmaceutical Company (NYSE: KVa/KVb) into one of the largest therapeutic categories in women's healthcare.
2,426 COMPANY PROFILE VIEWS
- This Page Viewed: (Last 7 Days: 4) (Last 30 Days: 16) (Since Published: 2426)